Pentrexcilina Triple Antibiotic
NDC Package 69729-080-33

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Pentrexcilina Triple Antibiotic is adults and children 2 years of age or older: clean the affected areaapply a small amount of this product (an amount equal tot the surface area of the tip of a finer) on the area 1 to 3 times dailymay be covered with a sterile bandagechildren under 2 years of age: ask a doctor. Marketed by Opmx Llc, this product is identified by NDC 69729-080 and is authorized under FDA application part333B.

Identification & Billing

NDC Package Code
69729-080-33
Package Description
1 TUBE in 1 BOX / 9.4 g in 1 TUBE
Product Code
69729-080
11-Digit Billing Format
69729008033
RxNorm Crosswalk
  • RxCUI: 204602 - bacitracin 400 UNT / neomycin 3.5 MG / polymyxin B 5000 UNT per GM Topical Ointment
  • RxCUI: 204602 - bacitracin 0.4 UNT/MG / neomycin 0.0035 MG/MG / polymyxin B 5 UNT/MG Topical Ointment
  • RxCUI: 204602 - bacitracin 400 UNT / neomycin 3.5 MG (as neomycin sulfate 5 MG) / polymyxin B 5000 UNT per GM Topical Ointment

Clinical Specifications

Proprietary Name
Pentrexcilina Triple Antibiotic
Dosage Form
-
Usage Information
Adults and children 2 years of age or older: clean the affected areaapply a small amount of this product (an amount equal tot the surface area of the tip of a finer) on the area 1 to 3 times dailymay be covered with a sterile bandagechildren under 2 years of age: ask a doctor

Regulatory & Marketing

Labeler Name
Opmx Llc
FDA Application #
part333B
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
08-01-2012
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69729-080-33 identifies a specific commercial package of 1 tube in 1 box / 9.4 g in 1 tube of Pentrexcilina Triple Antibiotic, labeled by Opmx Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Opmx Llc on August 01, 2012. The current certification is valid through December 31, 2017.

How is this Opmx Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69729008033. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69729-080-33
11-Digit CMS (5-4-2)
69729-0080-33

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.